Comparing the Effectiveness of Mikhled Knee Exercise Program and Quadriceps Based Training in Patellofemoral Pain Syndrome among Collegiate Athletes
DOI:
https://doi.org/10.37506/4zrjk776Keywords:
Patellofemoral pain syndrome, Kujala Patellofemoral scale, NPRS, Mikhled knee exercise program.Abstract
Background: Patellofemoral pain syndrome (PFPS) is a relatively common musculoskeletal condition that
produces pain at the front of the knee that may last for a long period. It is characterized by extensive pain in/
around the patella. Individuals commonly report an exacerbation of their symptoms when engaging in activities
that increase compressive load pressures in the joint.
Purpose: The purpose of the study is to determine the effects of Mikheld knee exercise program and quadriceps
based training in patellofemoral pain syndrome among collegiate athletes.
Material and Method: From November 2022 to April 2023, 54 participants with patellofemoral pain syndrome
were selected and randomly divided into two equal groups at Saveetha Medical College and Hospital .During
a four-week treatment session, Group A received a Mikheld knee exercise program, whereas Group B received
quadriceps-based training. Subjects were evaluated twice (pre-treatment and post-treatment) using the Numerical
Pain Rating Scale (NPRS) and the Kujala Patellofemoral Scale.
Results: Statistical analysis show that there is a significant change within-group for NPRS, kujala patellofemoral
scale in pre and post treatment, with a p value of < 0.0001, the mean of the Mikhled knee exercise program at the
post test was shown to be greater than the mean of quadriceps-based training.
Conclusion: According to the findings of this study, the Mikheld knee exercise program is more helpful in
participants suffering from patellofemoral pain syndrome than quadriceps-based training persons. The study was
limited by the small number of participants.
Downloads
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.